Table 1 |.
SNP | BP | EA | NEA | SJLIFE Europeans exposed to CRT (Discovery sample) | SJLIFE Africans exposed to CRT (Replication sample) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
EAFaff | EAFnon-aff | HR (95% CI) | P | EAFaff | EAFnon-aff | HR (95% CI) | P | |||||
rs112896372 | 3756587 | C | T | 0.27 | 0.16 | 2.55 (1.85–3.51) | 1.42×10−8 | 0.23 | 0.13 | 3.05 (1.10–8.50) | 0.034 | |
rs79103129 | 3760131 | A | G | 0.27 | 0.16 | 2.50 (1.82–3.44) | 2.24×10−8 | 0.05 | 0.04 | 1.43 (0.25–7.99) | 0.688 | |
rs4391171 | 3760305 | C | G | 0.27 | 0.16 | 2.50 (1.82–3.44) | 2.24×10−8 | 0.05 | 0.04 | 1.43 (0.25–7.99) | 0.688 | |
rs17652293 | 3760914 | G | C | 0.27 | 0.16 | 2.50 (1.82–3.44) | 2.24×10−8 | 0.05 | 0.04 | 1.43 (0.25–7.99) | 0.688 | |
rs35710183 | 3753773 | C | T | 0.28 | 0.17 | 2.36 (1.72–3.23) | 1.13×10−7 | 0.05 | 0.04 | 1.43 (0.25–7.99) | 0.688 |
Genomic positions are shown relative to GRCh38 (hg38); EA, effect allele; NEA, non-effect allele; EAF, effect allele frequency; EAFaff, EAF in survivors with stroke; EAFnon-aff, EAF in stroke-free survivors; HR, hazard ratio; CI, confidence interval; SJLIFE European-descent discovery sample (116 survivors with and 570 without stroke); SJLIFE African-descent replication sample (20 survivors with and 70 without stroke)